PTEN and neoplasm: That the protein expression of both HSP90 and HSP70 were reduced argues that our drug combination may utilize multiple pathways in any given tumor cell to cause cell death, explaining why cells that expressed activated oncogenes, such as RAS, or had inactivated tumor suppressor genes, such as PTEN, were all drug-combination sensitive.